0 programs across 0 drugs — copay cards, patient assistance and free-drug programs.
Manufacturer assistance is the first place a practice looks when a patient can’t cover their share of an infused drug. Each page below records the program’s eligibility rules, benefit cap, and how to apply, plus the date we last checked it against the manufacturer’s own page.
| Drug | Programs |
|---|
See the charitable fund status board for independent foundation funds, drug billing references for J-codes and units, and Medicare Part B coverage for covered diagnoses.
A copay card lowers what a commercially insured patient pays at the point of care, up to an annual cap set by the manufacturer. A patient assistance program supplies the drug at no cost to patients who meet income and insurance criteria. Patients with Medicare or Medicaid are generally excluded from manufacturer copay cards by federal anti-kickback rules, but may qualify for the free-drug program or an independent charitable foundation instead.
Generally no. Federal anti-kickback rules exclude government-insured patients from manufacturer copay assistance. Those patients are usually routed to the manufacturer’s free-drug program or to an independent charitable foundation fund covering the diagnosis.
Each program page carries its own status and the date it was last checked against the manufacturer’s official page. Programs open, close and change benefit caps without notice, so verify eligibility on the manufacturer’s site before relying on a figure.
Yes — those are tracked separately on the fund status board, which shows which disease funds are currently open, because foundation funds close and reopen far more often than manufacturer programs.
Program status changes without notice and stale assistance information costs patients real money. Every entry records the date it was last verified against the manufacturer’s official page; the process is described in our methodology. Spotted something wrong? Report an error.